Endocrinology Advisor11d
Gastrointestinal Adverse Events Mediate Some Tirzepatide-Associated Weight Loss
Gastrointestinal adverse events partially mediated the weight loss effects among patients with obesity who received tirzepatide vs placebo.
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Eli Lilly expects to read out results from a study in people with obesity and osteoarthritis of the knee in 2025.
Business Insider23d
See ya, knock-off Ozempic
The FDA is about to make it a lot harder to get cheap weight-loss drugs Jessica DeBenedetto has only been on compounded tirzepatide for a couple of weeks, but she already feels like it's a life ...
The Financial Express24d
Blockbuster weight loss drug Tirzepatide coming to India soon: Benefits, weight loss potential, and side effects
On the basis of the clinical trial data, patients on Zepbound (tirzepatide) 5mg weekly lost 16.1 kg (35.5 lb) on average after 72 weeks. For Zepbound’s 10mg weekly dose, the average weight loss ...
Medical News Today16d
How to Get Zepbound: Your Guide to Getting a Zepbound Prescription
Tirzepatide mimics the hormones GLP-1 and GIP, which a person’s stomach produces whenever they eat. These hormones reduce appetite, which can result in weight loss. You must also follow a ...
AOL28d
Mounjaro vs. Ozempic: Which One Is Best for Me to Try for Weight Loss in 2025?
It’s also FDA-approved to help those with type 2 diabetes manage blood sugar and prescribed off-label for weight loss. Zepbound is another brand name for tirzepatide — and this one is FDA ...